{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:17:33Z","timestamp":1793128653615,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GM1516A"],"award-info":[{"award-number":["01GM1516A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011199","name":"FP7 Ideas: European Research Council","doi-asserted-by":"publisher","award":["281234"],"award-info":[{"award-number":["281234"]}],"id":[{"id":"10.13039\/100011199","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014419","name":"EIT Health","doi-asserted-by":"publisher","award":["66691 BATCure"],"award-info":[{"award-number":["66691 BATCure"]}],"id":[{"id":"10.13039\/100014419","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ein Herz f\u00fcr Kinder - Bild hilft e.V."},{"name":"Freundeskreis UKE f\u00fcr Kinder mit Demenz e.V."},{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuroradiology"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Grey matter (GM) atrophy due to neuronal loss is a striking feature of patients with CLN3 disease. A precise and quantitative description of disease progression is needed in order to establish an evaluation tool for current and future experimental treatments. In order to develop a quantitative marker to measure brain volume outcome, we analysed the longitudinal volumetric development of GM, white matter (WM) and lateral ventricles and correlated those with the clinical course.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>One hundred twenty-two MRI scans of 35 patients (21 females; 14 males; age 15.3\u2009\u00b1\u20094.8\u00a0years) with genetically confirmed CLN3 disease were performed. A three-dimensional T1-weighted sequence was acquired with whole brain coverage. Volumetric segmentation of the brain was performed with the FreeSurfer image analysis suite. The clinical severity was assessed by the Hamburg jNCL score, a disease-specific scoring system.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The volumes of supratentorial cortical GM and supratentorial WM, cerebellar GM, basal ganglia\/thalamus and hippocampus significantly (<jats:italic>r<\/jats:italic>\u2009=\u2009\u2009\u2212\u20090.86 to\u2009\u2212\u20090.69, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001) decreased with age, while the lateral ventricle volume increased (<jats:italic>r<\/jats:italic>\u2009=\u20090.68, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). Supratentorial WM volume correlated poorer with age (<jats:italic>r<\/jats:italic>\u2009=\u2009\u2009\u2212\u20090.56, <jats:italic>p<\/jats:italic>\u2009=\u20090.0001). Supratentorial cortical GM volume showed the steepest (4.6% (\u00b1\u20090.2%)) and most uniform decrease with strongest correlation with age (<jats:italic>r<\/jats:italic>\u2009=\u2009\u2009\u2212\u20090.86, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). In addition, a strong correlation with disease specific clinical scoring existed for the supratentorial cortical GM volume (<jats:italic>r<\/jats:italic>\u2009=\u20090.85, <jats:italic>p<\/jats:italic>\u2009=\u2009\u2009&lt;\u20090.0001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Supratentorial cortical GM volume is a sensitive parameter for assessment of disease progression even in early and late disease stages and represents a potential reliable outcome measure for evaluation of experimental therapies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00234-022-02988-9","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T07:02:55Z","timestamp":1655190175000},"page":"2059-2067","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Natural history of MRI brain volumes in patients with neuronal ceroid lipofuscinosis 3: a sensitive imaging biomarker"],"prefix":"10.1007","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6699-9887","authenticated-orcid":false,"given":"Jan-Niklas","family":"Hochstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lezius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Grosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Fiehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sedlacik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"L\u00f6bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,14]]},"reference":[{"issue":"4","key":"2988_CR1","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1542\/peds.44.4.570","volume":"44","author":"W Zeman","year":"1969","unstructured":"Zeman W, Dyken P (1969) Neuronal ceroid-lipofuscinosis (Batten\u2019s disease): relationship to amaurotic family idiocy? Pediatrics 44(4):570\u201383","journal-title":"Pediatrics"},{"issue":"1","key":"2988_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnen\/62.1.1","volume":"62","author":"M Haltia","year":"2003","unstructured":"Haltia M (2003) The neuronal ceroid-lipofuscinoses. J Neuropathol Exp Neurol 62(1):1\u201313. https:\/\/doi.org\/10.1093\/jnen\/62.1.1","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"2988_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10048-005-0218-3","volume":"6","author":"SE Mole","year":"2005","unstructured":"Mole SE, Williams RE, Goebel H (2005) Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics 6(3):107\u201326. https:\/\/doi.org\/10.1007\/s10048-005-0218-3","journal-title":"Neurogenetics"},{"issue":"11","key":"2988_CR4","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/j.bbadis.2013.03.017","volume":"1832","author":"V Warrier","year":"2013","unstructured":"Warrier V, Vieira M, Mole SE (2013) Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses. Biochim Biophys Acta 1832(11):1827\u201330. https:\/\/doi.org\/10.1016\/j.bbadis.2013.03.017","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"2988_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1212\/WNL.0b013e31825f0547","volume":"79","author":"RE Williams","year":"2012","unstructured":"Williams RE, Mole SE (2012) New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses. Neurology 79(2):183\u201391. https:\/\/doi.org\/10.1212\/WNL.0b013e31825f0547","journal-title":"Neurology"},{"issue":"1","key":"2988_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/humu.21624","volume":"33","author":"M Kousi","year":"2012","unstructured":"Kousi M, Lehesjoki AE, Mole SE (2012) Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses. Hum Mutat 33(1):42\u201363. https:\/\/doi.org\/10.1002\/humu.21624","journal-title":"Hum Mutat"},{"key":"2988_CR7","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/ajmg.1320420422","volume":"42","author":"M Claussen","year":"1992","unstructured":"Claussen M, Heim P, Knispel J, Goebel HH, Kohlsch\u00fctter A (1992) Incidence of neuronal ceroid-lipofuscinoses in West Germany: variation of a method for studying autosomal recessive disorders. Am J Med Genet 42:536\u2013538. https:\/\/doi.org\/10.1002\/ajmg.1320420422","journal-title":"Am J Med Genet"},{"issue":"1","key":"2988_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1055\/s-2007-973654","volume":"28","author":"P Uvebrant","year":"1997","unstructured":"Uvebrant P, Hagberg B (1997) Neuronal ceroid lipofuscinoses in Scandinavia. Epidemiology and clinical pictures. Neuropediatrics 28(1):6\u20138. https:\/\/doi.org\/10.1055\/s-2007-973654","journal-title":"Neuropediatrics"},{"issue":"3","key":"2988_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1399-0004.2008.01054.x","volume":"74","author":"SJ Moore","year":"2008","unstructured":"Moore SJ, Buckley DJ, MacMillan A et al (2008) The clinical and genetic epidemiology of neuronal ceroid lipofuscinosis in Newfoundland. Clin Genet 74(3):213\u201322. https:\/\/doi.org\/10.1111\/j.1399-0004.2008.01054.x","journal-title":"Clin Genet"},{"issue":"11","key":"2988_CR10","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/j.bbadis.2013.04.008","volume":"1832","author":"A Schulz","year":"2013","unstructured":"Schulz A, Kohlsch\u00fctter A, Mink J, Simonati A, Williams R (2013) NCL diseases - clinical perspectives. Biochim Biophys Acta 1832(11):1801\u20136. https:\/\/doi.org\/10.1016\/j.bbadis.2013.04.008","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"2988_CR11","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/j.1651-2227.1988.tb10770.x","volume":"77","author":"A Kohlsch\u00fctter","year":"1988","unstructured":"Kohlsch\u00fctter A, Laabs R, Albani M (1988) Juvenile neuronal ceroid lipofuscinosis (JNCL): quantitative description of its clinical variability. Acta Paediatr Scand 77(6):867\u201372. https:\/\/doi.org\/10.1111\/j.1651-2227.1988.tb10770.x","journal-title":"Acta Paediatr Scand"},{"issue":"3","key":"2988_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ymgme.2008.01.001","volume":"93","author":"D Rakheja","year":"2008","unstructured":"Rakheja D, Narayan SB, Bennett MJ (2008) The function of CLN3P, the batten disease protein. Mol Genet Metab 93(3):269\u201374. https:\/\/doi.org\/10.1016\/j.ymgme.2008.01.001","journal-title":"Mol Genet Metab"},{"key":"2988_CR13","unstructured":"NCL Resource - a gateway for Batten disease. https:\/\/www.ucl.ac.uk\/ncl-disease\/mutation-and-patient-database\/mutation-and-patient-datasheets-human-ncl-genes\/cln3. Accessed 23 Oct 2021"},{"key":"2988_CR14","doi-asserted-by":"publisher","first-page":"136117","DOI":"10.1016\/j.neulet.2021.136117","volume":"762","author":"SL Cotman","year":"2021","unstructured":"Cotman SL, Lefrancois S (2021) CLN3, at the crossroads of endocytic trafficking. Neurosci Lett 762:136117. https:\/\/doi.org\/10.1016\/j.neulet.2021.136117","journal-title":"Neurosci Lett"},{"issue":"1","key":"2988_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S1474-4422(18)30368-5","volume":"18","author":"SE Mole","year":"2019","unstructured":"Mole SE, Anderson G, Band HA et al (2019) Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis. Lancet Neurol 18(1):107\u2013116. https:\/\/doi.org\/10.1016\/S1474-4422(18)30368-5","journal-title":"Lancet Neurol"},{"issue":"4","key":"2988_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s40263-019-00620-8","volume":"33","author":"A Kohlsch\u00fctter","year":"2019","unstructured":"Kohlsch\u00fctter A, Schulz A, Bartsch U, Storch S (2019) Current and emerging treatment strategies for neuronal ceroid lipofuscinoses. CNS Drugs 33(4):315\u2013325. https:\/\/doi.org\/10.1007\/s40263-019-00620-8","journal-title":"CNS Drugs"},{"key":"2988_CR17","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.3174\/ajnr.A4816","volume":"37","author":"U L\u00f6bel","year":"2016","unstructured":"L\u00f6bel U, Sedlacik J, Nickel M et al (2016) Volumetric description of brain atrophy in neuronal ceroid lipofuscinosis 2: supratentorial gray matter shows uniform disease progression. Am J Neuroradiol 37:1938\u20131943. https:\/\/doi.org\/10.3174\/ajnr.A4816","journal-title":"Am J Neuroradiol"},{"issue":"6","key":"2988_CR18","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.3174\/ajnr.A4669","volume":"37","author":"JP Dyke","year":"2016","unstructured":"Dyke JP, Sondhi D, Voss HU et al (2016) Brain region-specific degeneration with disease progression in late infantile neuronal ceroid lipofuscinosis (CLN2 disease). AJNR Am J Neuroradiol 37(6):1160\u20139. https:\/\/doi.org\/10.3174\/ajnr.A4669","journal-title":"AJNR Am J Neuroradiol"},{"issue":"20","key":"2988_CR19","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","volume":"378","author":"A Schulz","year":"2018","unstructured":"Schulz A, Ajayi T, Specchio N et al (2018) Study of intraventricular cerliponase alfa for CLN2 disease. N Engl J Med 378(20):1898\u20131907. https:\/\/doi.org\/10.1056\/NEJMoa1712649","journal-title":"N Engl J Med"},{"issue":"5","key":"2988_CR20","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/BF00607283","volume":"38","author":"T Autti","year":"1996","unstructured":"Autti T, Raininko R, Vanhanen SL, Santavuori P (1996) MRI of neuronal ceroid lipofuscinosis I. Cranial MRI of 30 patients with juvenile neuronal ceroid lipofuscinosis. Neuroradiology 38(5):476\u201382. https:\/\/doi.org\/10.1007\/BF00607283","journal-title":"Neuroradiology"},{"issue":"5","key":"2988_CR21","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/ana.410420517","volume":"42","author":"I J\u00e4rvel\u00e4","year":"1997","unstructured":"J\u00e4rvel\u00e4 I, Autti T, Santavuori P, Raininko R, \u00c5berg L, Peltonen L (1997) Clinical and MRI findings in Batten disease \u2013 analysis of the major mutation. Ann Neurol 42(5):799\u2013802. https:\/\/doi.org\/10.1002\/ana.410420517","journal-title":"Ann Neurol"},{"issue":"8","key":"2988_CR22","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1007\/s00415-008-0891-x","volume":"255","author":"TH Autti","year":"2008","unstructured":"Autti TH, H\u00e4m\u00e4l\u00e4inen J, Mannerkoski M et al (2008) JNCL patients show marked brain volume alterations on longitudinal MRI in adolescence. J Neurol 255(8):1226\u201330. https:\/\/doi.org\/10.1007\/s00415-008-0891-x","journal-title":"J Neurol"},{"issue":"2","key":"2988_CR23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.pediatrneurol.2013.10.013","volume":"50","author":"AM Tokola","year":"2014","unstructured":"Tokola AM, Eero KS, \u00c5berg LE, Autti T (2014) hippocampal volumes in juvenile neuronal ceroid lipofuscinosis: a longitudinal magnetic resonance imaging study. Pediatr Neurol 50(2):158\u201363. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2013.10.013","journal-title":"Pediatr Neurol"},{"issue":"4","key":"2988_CR24","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/j.neuroimage.2012.02.084","volume":"61","author":"M Reuter","year":"2012","unstructured":"Reuter M, Schmansky NJ, Rosas HD, Fischl B (2012) Within-subject template estimation for unbiased longitudinal image analysis. Neuroimage 61(4):1402\u201318. https:\/\/doi.org\/10.1016\/j.neuroimage.2012.02.084","journal-title":"Neuroimage"},{"issue":"1","key":"2988_CR25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.neuroimage.2006.02.051","volume":"32","author":"X Han","year":"2006","unstructured":"Han X, Jovicich J, Salat D et al (2006) Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. Neuroimage 32(1):180\u201394. https:\/\/doi.org\/10.1016\/j.neuroimage.2006.02.051","journal-title":"Neuroimage"},{"issue":"4","key":"2988_CR26","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3174\/ajnr.A3297","volume":"34","author":"JP Dyke","year":"2013","unstructured":"Dyke JP, Sondhi D, Voss HU et al (2013) Assessment of disease severity in late infantile neuronal ceroid lipofuscinosis using multiparametric MR imaging. AJNR Am J Neuroradiol 34(4):884\u20139. https:\/\/doi.org\/10.3174\/ajnr.A3297","journal-title":"AJNR Am J Neuroradiol"},{"issue":"10","key":"2988_CR27","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.3174\/ajnr.A6726","volume":"41","author":"A Biswas","year":"2020","unstructured":"Biswas A, Krishnan P, Amirabadi A et al (2020) Expanding the neuroimaging phenotype of neuronal ceroid lipofuscinoses. AJNR Am J Neuroradiol 41(10):1930\u20131936. https:\/\/doi.org\/10.3174\/ajnr.A6726","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"2988_CR28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1212\/01.wnl.0000169019.41332.8a","volume":"65","author":"FJ Marshall","year":"2005","unstructured":"Marshall FJ, de Blieck EA, Mink JW et al (2005) A clinical rating scale for Batten disease: reliable and relevant for clinical trials. Neurology 65(2):275\u20139. https:\/\/doi.org\/10.1212\/01.wnl.0000169019.41332.8a","journal-title":"Neurology"},{"issue":"100","key":"2988_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neubiorev.2013.12.004","volume":"39","author":"ANV Ruigrok","year":"2014","unstructured":"Ruigrok ANV, Salimi-Khorshidi G, Lai MC et al (2014) A meta-analysis of sex differences in human brain structure. Neurosci Biobehav Rev 39(100):34\u201350. https:\/\/doi.org\/10.1016\/j.neubiorev.2013.12.004","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"2988_CR30","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10545-011-9421-6","volume":"35","author":"J Cialone","year":"2012","unstructured":"Cialone J, Adams H, Augustine EF et al (2012) Females experience a more severe disease course in Batten disease. J Inherit Metab Dis 35(3):549\u201355. https:\/\/doi.org\/10.1007\/s10545-011-9421-6","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"2988_CR31","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s00221-006-0732-z","volume":"178","author":"M Wilke","year":"2007","unstructured":"Wilke M, Kr\u00e4geloh-Mann I, Holland SK (2007) Global and local development of gray and white matter volume in normal children and adolescents. Exp Brain Res 178(3):296\u2013307. https:\/\/doi.org\/10.1007\/s00221-006-0732-z","journal-title":"Exp Brain Res"},{"issue":"4","key":"2988_CR32","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1093\/cercor\/6.4.551","volume":"6","author":"JN Giedd","year":"1996","unstructured":"Giedd JN, Snell JW, Lange N et al (1996) Quantitative magnetic resonance imaging of human brain development: ages 4\u201318. Cereb Cortex 6(4):551\u2013560. https:\/\/doi.org\/10.1093\/cercor\/6.4.551","journal-title":"Cereb Cortex"},{"issue":"10","key":"2988_CR33","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/13158","volume":"2","author":"JN Giedd","year":"1999","unstructured":"Giedd JN, Blumenthal J, Jeffries NO et al (1999) Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci 2(10):861\u20133. https:\/\/doi.org\/10.1038\/13158","journal-title":"Nat Neurosci"},{"issue":"3","key":"2988_CR34","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","volume":"33","author":"B Fischl","year":"2002","unstructured":"Fischl B, Salat D, Busa E et al (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33(3):341\u201355. https:\/\/doi.org\/10.1016\/S0896-6273(02)00569-X","journal-title":"Neuron"}],"container-title":["Neuroradiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-022-02988-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00234-022-02988-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-022-02988-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T09:14:39Z","timestamp":1663146879000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00234-022-02988-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,14]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["2988"],"URL":"https:\/\/doi.org\/10.1007\/s00234-022-02988-9","relation":{},"ISSN":["0028-3940","1432-1920"],"issn-type":[{"value":"0028-3940","type":"print"},{"value":"1432-1920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,14]]},"assertion":[{"value":"22 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliances with Ethical standards"}},{"value":"The study protocol of this observational study was approved by the local ethical committee of the \u00c4rztekammer Hamburg (PV7215). The procedures used in this study are in line with the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained for all patients prior to enrolment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The research leading to these results has received funding from the German Federal Ministry of Education and Research (Grant NCL2Treat to AS, Grant No. 01GM1516A), the European Union\u2019s Seventh Framework Program (grant agreement No. 281234, DEM-CHILD to AS), and the European Horizon 2020 research and innovation program (grant agreement No. 66691 BATCure to AS). In addition, the work leading to this data collection was generously supported by fundraising by \u201cFreundeskreis UKE f\u00fcr Kinder mit Demenz e.V.\u201d and \u201cEin Herz f\u00fcr Kinder \u2013 Bild hilft e.V.\u201d.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}